Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz Schaefer

Showing results (391-400 of 505) with videos related to

Pageof 51
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|November 10, 2016
Cardiovascular Phenotypes in Children with CKD: The 4C StudyFranz Schaefer, Anke Doyon, Karolis Azukaitis, et al.
Kidney International|September 3, 2010
The bone and mineral disorder of children undergoing chronic peritoneal dialysisDagmara Borzych, Lesley Rees, Il Soo Ha, et al.
Eclinicalmedicine|July 25, 2024
Changes in the cardiovascular risk profile in children approaching kidney replacement therapyPriyanka Khandelwal, Jonas Hofstetter, Karolis Azukaitis, et al.
Kidney International Reports|July 13, 2023
Clinical Characteristics and Courses of Patients With Autosomal Recessive Polycystic Kidney Disease-Mimicking PhenocopiesAbdul A Halawi, Kathrin Burgmaier, Anja K Buescher, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 1, 2016
Peritoneal Dialysis Access Revision in Children: Causes, Interventions, and OutcomesDagmara Borzych-Duzalka, T Fazil Aki, Marta Azocar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2016
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best PracticeRon T Gansevoort, Mustafa Arici, Thomas Benzing, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 4, 2020
Patient- and parent proxy-reported outcome measures for life participation in children with chronic kidney disease: a systematic reviewJasmijn Kerklaan, Elyssa Hannan, Amanda Baumgart, et al.
Kidney International|September 16, 2011
Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)Gary R Matzke, George R Aronoff, Arthur J Atkinson, et al.
Pediatric Nephrology (Berlin, Germany)|July 21, 2014
Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA-EDTA registryNicholas Chesnaye, Marjolein Bonthuis, Franz Schaefer, et al.
Kidney International Reports|June 20, 2024
Prospective Study of Modifiable Risk Factors of Arterial Hypertension and Left Ventricular Hypertrophy in Pediatric Patients on HemodialysisDagmara Borzych-Dużałka, Rukshana Shroff, Bruno Ranchin, et al.
Pageof 51

Showing results (391-400 of 505) with videos related to

Sort By:
Pageof 51
Clinical Journal of the American Society of Nephrology : CJASN|November 10, 2016
Cardiovascular Phenotypes in Children with CKD: The 4C StudyFranz Schaefer, Anke Doyon, Karolis Azukaitis, et al.
Kidney International|September 3, 2010
The bone and mineral disorder of children undergoing chronic peritoneal dialysisDagmara Borzych, Lesley Rees, Il Soo Ha, et al.
Eclinicalmedicine|July 25, 2024
Changes in the cardiovascular risk profile in children approaching kidney replacement therapyPriyanka Khandelwal, Jonas Hofstetter, Karolis Azukaitis, et al.
Kidney International Reports|July 13, 2023
Clinical Characteristics and Courses of Patients With Autosomal Recessive Polycystic Kidney Disease-Mimicking PhenocopiesAbdul A Halawi, Kathrin Burgmaier, Anja K Buescher, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 1, 2016
Peritoneal Dialysis Access Revision in Children: Causes, Interventions, and OutcomesDagmara Borzych-Duzalka, T Fazil Aki, Marta Azocar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2016
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best PracticeRon T Gansevoort, Mustafa Arici, Thomas Benzing, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 4, 2020
Patient- and parent proxy-reported outcome measures for life participation in children with chronic kidney disease: a systematic reviewJasmijn Kerklaan, Elyssa Hannan, Amanda Baumgart, et al.
Kidney International|September 16, 2011
Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)Gary R Matzke, George R Aronoff, Arthur J Atkinson, et al.
Pediatric Nephrology (Berlin, Germany)|July 21, 2014
Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA-EDTA registryNicholas Chesnaye, Marjolein Bonthuis, Franz Schaefer, et al.
Kidney International Reports|June 20, 2024
Prospective Study of Modifiable Risk Factors of Arterial Hypertension and Left Ventricular Hypertrophy in Pediatric Patients on HemodialysisDagmara Borzych-Dużałka, Rukshana Shroff, Bruno Ranchin, et al.
Pageof 51